These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10539807)

  • 21. [Renal function after administration of angiotensin-converting enzyme inhibitors].
    Waeber B; Burnier M; Nussberger J; Brunner HR
    Schweiz Med Wochenschr; 1987 Sep; 117(37):1359-62. PubMed ID: 3672075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deterioration in renal function with enalapril but not losartan in a patient with renal artery stenosis in a solitary kidney.
    Missouris CG; Ward DE; Eastwood JB; MacGregor GA
    Heart; 1997 Apr; 77(4):391-2. PubMed ID: 9155634
    [No Abstract]   [Full Text] [Related]  

  • 23. [Converting enzyme inhibitors in preterminal renal failure].
    Rambausek MH; Ritz E
    Dtsch Med Wochenschr; 1992 Jan; 117(2):77. PubMed ID: 1730207
    [No Abstract]   [Full Text] [Related]  

  • 24. [ACE inhibitors in kidney diseases--only another antihypertensive agent?].
    Ritz E; Stein G
    Med Klin (Munich); 1994 Sep; 89(9):473-5. PubMed ID: 7968882
    [No Abstract]   [Full Text] [Related]  

  • 25. Left ventricular function and response to enalapril in patients with Duchenne muscular dystrophy during the second decade of life.
    Giglio V
    Am J Cardiol; 2007 Jan; 99(1):147-8. PubMed ID: 17196482
    [No Abstract]   [Full Text] [Related]  

  • 26. The angiotensin converting enzyme inhibitor enalapril and its effects on renal function.
    de Zeeuw D; Navis GJ; Donker AJ; de Jong PE
    J Hypertens Suppl; 1983 Oct; 1(1):93-7. PubMed ID: 6100614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Losartan and enalapril are comparable in reducing proteinuria in children.
    Webb NJ; Shahinfar S; Wells TG; Massaad R; Gleim GW; Santoro EP; Sisk CM; Lam C
    Kidney Int; 2012 Oct; 82(7):819-26. PubMed ID: 22739977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does the duration of action of angiotensin converting enzyme inhibitors affect their safety and adverse effects?
    Frank GJ
    J Hypertens Suppl; 1989 Sep; 7(5):S17-22. PubMed ID: 2553900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute and long-term effects of the angiotensin-converting enzyme inhibitor, enalapril, on adrenergic activity and sensitivity during exercise in patients with left ventricular systolic dysfunction.
    Patten RD; Kronenberg MW; Benedict CR; Udelson JE; Kinan D; Stewart D; Yusuf S; Smith JJ; Kilcoyne L; Dolan N; Edens TR; Metherall J; Konstam MA
    Am Heart J; 1997 Jul; 134(1):37-43. PubMed ID: 9266781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).
    Komajda M; Lutiger B; Madeira H; Thygesen K; Bobbio M; Hildebrandt P; Jaarsma W; Riegger G; Rydén L; Scherhag A; Soler-Soler J; Remme WJ;
    Eur J Heart Fail; 2004 Jun; 6(4):467-75. PubMed ID: 15182773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Commentary on Kostis' report from SOLVD.
    Gavras I; Gavras H
    Am J Hypertens; 1996 Jun; 9(6):615, 616-9. PubMed ID: 8783788
    [No Abstract]   [Full Text] [Related]  

  • 32. Questions regarding Kostis' article on SOLVD.
    Borhani NO
    Am J Hypertens; 1996 Jun; 9(6):615-9. PubMed ID: 8783789
    [No Abstract]   [Full Text] [Related]  

  • 33. Missing explanation on enalapril monotherapy.
    Cheng TO
    Am J Hypertens; 1997 Mar; 10(3):366. PubMed ID: 9056696
    [No Abstract]   [Full Text] [Related]  

  • 34. ACE inhibitors captopril and enalapril induce regression of left ventricular hypertrophy in hypertensive patients with chronic renal failure.
    Dyadyk AI; Bagriy AE; Lebed IA; Yarovaya NF; Schukina EV; Taradin GG
    Nephrol Dial Transplant; 1997 May; 12(5):945-51. PubMed ID: 9175047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Converting enzyme inhibition and left ventricular hypertrophy.
    Fagard R
    Eur Heart J; 1995 Dec; 16(12):1748-9. PubMed ID: 8681996
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of comorbidities on outcomes and angiotensin converting enzyme inhibitor effects in patients with predominantly left ventricular dysfunction and heart failure.
    Böhm M; Pogue J; Kindermann I; Pöss J; Koon T; Yusuf S
    Eur J Heart Fail; 2014 Mar; 16(3):325-33. PubMed ID: 24464788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [ACE inhibitors and the kidney].
    Hörl WH
    Wien Med Wochenschr; 1996; 146(11):231-4; discussion 234-5. PubMed ID: 8928521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diuretics potentiate the angiotensin converting-enzyme inhibitor-associated acute renal dysfunction.
    Lee HC; Pettinger WA
    Clin Nephrol; 1992 Oct; 38(4):236-7. PubMed ID: 1424316
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cost effectiveness of ACE inhibition in therapy of chronic heart failure in Switzerland: evaluation based on the SOLVD study].
    Szucs TD; Goedde M; Berger K; Kiowski W
    Schweiz Med Wochenschr; 1997 Jul; 127(29-30):1234-41. PubMed ID: 9333933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Perspectives for enalapril in the therapy of coronary heart disease. European Cardiology Symposium, Montreux, February 1997].
    Dtsch Med Wochenschr; 1997; 122(21 Suppl Perspektiv):1-8. PubMed ID: 9439478
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.